Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for differentiating human pluripotent stem cells into natural killer cells and application

A technology of natural killer cells and pluripotent stem cells, applied in the field of stem cell biology, can solve the problems of long differentiation cycle, low differentiation efficiency and purity, dependence on feeder cells, etc., and achieve short cycle, low cost and clear composition Effect

Active Publication Date: 2020-06-05
安徽中盛溯源生物科技有限公司
View PDF7 Cites 23 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] Although the process of in vitro differentiation from pluripotent stem cells into natural killer cells has been relatively clear at the principle level, and there are currently many methods for inducing differentiation, but the existing differentiation methods may have long differentiation cycles, low differentiation efficiency and purity, and poor differentiation. Unknown components, dependence on feeder cells, complex operation and high cost, so it is difficult to expand production and clinical use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for differentiating human pluripotent stem cells into natural killer cells and application
  • Method for differentiating human pluripotent stem cells into natural killer cells and application
  • Method for differentiating human pluripotent stem cells into natural killer cells and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0136] This embodiment discloses a method for preparing natural killer cells, comprising the following steps:

[0137] S1: Formation of embryoid bodies;

[0138] S2: Differentiation of embryoid bodies to hematopoietic progenitor cells;

[0139] S3: differentiation of hematopoietic progenitor cells into NK cells;

[0140] S4: Maturation and expansion of NK cells.

[0141] Specifically, the flow chart is as figure 1 As shown, the steps are as follows:

[0142] (1) Day-1~Day 0: Formation of embryoid body (EB)

[0143] 1) Culture of human pluripotent stem cells (iPSCs)

[0144] The human iPSCs used in the experiment have undergone strict pluripotency verification (expressing various pluripotency markers, and can form teratomas including inner, middle and outer germ layers in immunodeficient mice). iPSCs are normally cultured in iPSC maintenance medium, the medium used is E8 or TeSR or other similar medium.

[0145] The human iPSC is prepared by the method disclosed in the ...

Embodiment 2

[0193] This example studies the effects of different EB culture methods on the EB differentiation rate. In the experimental group, the culture method of 3D suspension culture to form embryoid bodies was adopted throughout the induction and differentiation process, that is, the iPSCs were directly formed into smaller volume EBs on a 3D shaker, and then replaced with different special differentiation media at different differentiation stages ( Concrete steps refer to embodiment 1). During the culture process, the volume of EB gradually increased, and the cells continued to proliferate. Compared with the 2D differentiation scheme (see patent CN107429230A), the 3D differentiation condition greatly saves the culture space and culture volume, and the number of cells obtained under the same culture system is significantly increased, which is conducive to the scale-up of hPSCs to multipotential blood precursor cells Production. Compared with the differentiation scheme of Spin EB (US...

Embodiment 3

[0195] The present invention finds that in 3D induction culture, the use of small molecule reagents, cytokines and cell matrix can replace serum and trophoblast cells, and accelerate the differentiation process and improve the differentiation efficiency, which is beneficial to the production of subsequent clinical-grade cell preparations.

[0196] In our differentiation method, in addition to using 3D to improve differentiation efficiency, the combined use of small molecule reagents, cytokines, and cell substrates not only avoids the use of serum and trophoblast cells, but also further increases the proportion of blood precursor cells. CHIR99021 was selected as the GSK3β inhibitor, BMP4 was used as the BMP signaling pathway activator, SB431542 was used as the Nodal inhibitor, and DLL4-Fc recombinant protein was used as the Notch signaling pathway activator in the cell matrix. On days 6-12, the ratio of blood progenitor cells (CD34+) obtained can be as high as 20-80%, which is h...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Cell densityaaaaaaaaaa
Login to View More

Abstract

The invention relates to the field of stem cell biology, specifically to a method for differentiating human pluripotent stem cells into natural killer cells and an application. The invention disclosesa pluripotent stem cell-derived natural killer cell. The pluripotent stem cell-derived natural killer cell expresses CD56, Nkp30, Nkp44 and Nkp46, and also expresses markers CD16 and CD94 of a maturenatural killer cell. The invention also discloses a method for preparing the natural killer cell. The method comprises the following steps: S1, formation of an embryoid body; S2, differentiation of the embryoid body into hematopoietic progenitor cells; S3, differentiation of the hematopoietic progenitor cells into NK cells; and S4, maturation and expansion of the NK cells. With the differentiation method provided by the invention, the pluripotent stem cells can be rapidly, efficiently, simply and conveniently induced to be differentiated into the natural killer cells with low cost on the basis of a culture medium with definite components and an optimized cell factor combination.

Description

technical field [0001] The present invention relates to the field of stem cell biology, in particular to the lineage-specific differentiation of multipotent or multipotent stem cells, in particular to a method and application for differentiating human pluripotent stem cells into natural killer cells. Background technique [0002] According to the latest national cancer report in 2018, the estimated number of new cases of malignant tumors nationwide in 2014 was 3.804 million, and an average of more than 10,000 people were diagnosed with cancer every day. The incidence rate of tumor was 278.07 / 100,000, the cumulative incidence rate of 0-74 years old was 21.58%, and the cumulative mortality rate was 12.00%. In 2013, "Science" magazine listed tumor immunotherapy as the first of the top ten scientific breakthroughs. Immunotherapy has become a new generation of tumor treatment after surgery, chemotherapy, radiotherapy, and tumor targeted therapy, bringing new benefits to the treat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/0783C12N5/074A01N1/02A61K35/17A61P35/00
CPCA01N1/0221A61K35/17A61P35/00C12N5/0646C12N2500/80C12N2501/105C12N2501/11C12N2501/115C12N2501/125C12N2501/135C12N2501/14C12N2501/145C12N2501/155C12N2501/165C12N2501/22C12N2501/2301C12N2501/2302C12N2501/2303C12N2501/2306C12N2501/2307C12N2501/2312C12N2501/2318C12N2501/2321C12N2501/2327C12N2501/26C12N2501/33C12N2501/405C12N2501/58C12N2506/45C12N2513/00C12N2533/50C12N2533/52
Inventor 不公告发明人
Owner 安徽中盛溯源生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com